"I’m not going to make that kind of commitment," replied CDC director Kennedy when asked if he'd support vaccine guidance from Dr Schwartz. HealthDay News — During a tense congressional hearing ...

A new effort to prepare for future bird flu outbreaks is moving forward, despite a major funding setback. The American pharmaceutical and biotechnology company Moderna has initiated a large clinical ...

Sources familiar with the decision who spoke to The Post anonymously said the report had passed the CDC’s scientific review before the delay.

By targeting underlying synovitis, the novel intra-articular liraglutide formulation 4P004 aims to bridge the gap between transient symptom relief and disease modification in knee OA.

The expanded approval was based on the single-arm, non-randomized, open-label phase 4 PETITE-T1D study, which evaluated the safety and pharmacokinetics of teplizumab.

Dr Erica Schwartz, nominated to lead the US Centers for Disease Control and Prevention, is highly qualified, according to ...

Gabapentinoids are associated with an increased risk for drug poisoning, particularly in the short-term after initiation, according to a study published online ...